Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-035787
Filing Date
2023-06-09
Accepted
2023-06-09 16:15:36
Documents
1
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4274
  Complete submission text file 0001209191-23-035787.txt   5842
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 91 JAMES AVENUE ATHERTON CA 94027
Business Address
KING THOMAS BRAXTON (Reporting) CIK: 0001279309 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 231005463